Myotonic and neuromuscular blocking effects of increased doses of suxamethonium in infants and children
- PMID: 2265051
- DOI: 10.1093/bja/65.6.816
Myotonic and neuromuscular blocking effects of increased doses of suxamethonium in infants and children
Abstract
The myotonic effects and duration of action of several doses of suxamethonium were determined in 24 infants and 16 children during thiopentone-fentanyl-nitrous oxide anaesthesia. Infants received suxamethonium 2, 3 or 4 mg kg-1; children received 1 or 2 mg kg-1. The increase in muscle tone during onset of neuromuscular block was independent of dose. Onset of block was faster in children who received suxamethonium 2 mg kg-1 compared with those who received 1 mg kg-1, and in infants given 2 mg kg-1 than in children given the same dose. Compared with adults given suxamethonium 1 mg kg-1, infants required 3-4 mg kg-1 and children at least 2 mg kg-1 to produce 6-8 min of neuromuscular block. These results provide a clear indication for increasing the intubating doses of suxamethonium in infants and children, and a explanation for the unduly high rate of "masseter spasm" in some paediatric centres.
Similar articles
-
Dose-response curves for suxamethonium in neonates, infants and children.Br J Anaesth. 1989 Jun;62(6):655-8. doi: 10.1093/bja/62.6.655. Br J Anaesth. 1989. PMID: 2751920 Clinical Trial.
-
Comparison of the neuromuscular effects of mivacurium and suxamethonium in infants and children.Acta Anaesthesiol Scand Suppl. 1995;106:35-40. doi: 10.1111/j.1399-6576.1995.tb04307.x. Acta Anaesthesiol Scand Suppl. 1995. PMID: 8533543 Clinical Trial.
-
Does suxamethonium influence the subsequent dose requirements of alcuronium and its reversibility in children?Anaesth Intensive Care. 1990 Nov;18(4):479-82. doi: 10.1177/0310057X9001800411. Anaesth Intensive Care. 1990. PMID: 2268013
-
[Is suxamethonium still useful for paediatric anaesthesia?].Anestezjol Intens Ter. 2011 Jul-Sep;43(3):181-5. Anestezjol Intens Ter. 2011. PMID: 22011924 Review. Polish.
-
Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia.Drugs. 1993 Jun;45(6):1066-1089. doi: 10.2165/00003495-199345060-00009. Drugs. 1993. PMID: 7691494 Review.
Cited by
-
Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.Drug Saf. 1994 May;10(5):331-49. doi: 10.2165/00002018-199410050-00001. Drug Saf. 1994. PMID: 8037887 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources